Research Options:
Week of Expected Pricing Withdrawn
Company Name CANCER PREVENTION PHARMACEUTICALS, INC.
Proposed Ticker CPP
CUSIP 13740W107
Business Description A clinical-stage biopharmaceutical company formed primarily to develop and commercialize therapeutic agents for the treatment and prevention of certain pre-cancerous conditions, orphan diseases (i.e., rare diseases) and gastrointestinal conditions.
Lead Underwriter Aegis Capital Corp.
Co-Managers N/A
Initial Shares 1,923,076
Revised Initial Shares 1,250,000
Initial Price $12.00-$14.00
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 
   
  © 2024 ICE Data Services. All rights reserved.